25 XP   0   0   10

Yuyu Pharma Inc
Buy, Hold or Sell?

Let's analyse Yuyu together

PenkeI guess you are interested in Yuyu Pharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Yuyu Pharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Yuyu Pharma Inc

I send you an email if I find something interesting about Yuyu Pharma Inc.

Quick analysis of Yuyu (30 sec.)










What can you expect buying and holding a share of Yuyu? (30 sec.)

How much money do you get?

How much money do you get?
₩0.35
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
₩7,437.32
Expected worth in 1 year
₩7,005.03
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
₩62.50
Return On Investment
0.6%

For what price can you sell your share?

Current Price per Share
₩10,900.00
Expected price per share
₩9,850 - ₩11,820
How sure are you?
50%

1. Valuation of Yuyu (5 min.)




Live pricePrice per Share (EOD)

₩10,900.00

Intrinsic Value Per Share

₩-2,453.24 - ₩9,415.33

Total Value Per Share

₩4,984.07 - ₩16,852.64

2. Growth of Yuyu (5 min.)




Is Yuyu growing?

Current yearPrevious yearGrowGrow %
How rich?$84.2m$86.3m-$2.1m-2.5%

How much money is Yuyu making?

Current yearPrevious yearGrowGrow %
Making money-$5m-$4.1m-$835.2k-16.6%
Net Profit Margin-5.2%-4.3%--

How much money comes from the company's main activities?

3. Financial Health of Yuyu (5 min.)




What can you expect buying and holding a share of Yuyu? (5 min.)

Welcome investor! Yuyu's management wants to use your money to grow the business. In return you get a share of Yuyu.

What can you expect buying and holding a share of Yuyu?

First you should know what it really means to hold a share of Yuyu. And how you can make/lose money.

Speculation

The Price per Share of Yuyu is ₩10,900. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Yuyu.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Yuyu, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩7,437.32. Based on the TTM, the Book Value Change Per Share is ₩-108.07 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-180.75 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩123.70 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Yuyu.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.310.0%-0.310.0%-0.270.0%-0.070.0%0.000.0%
Usd Book Value Change Per Share-0.080.0%-0.080.0%-0.130.0%0.000.0%0.520.0%
Usd Dividend Per Share0.090.0%0.090.0%0.090.0%0.080.0%0.100.0%
Usd Total Gains Per Share0.010.0%0.010.0%-0.040.0%0.090.0%0.620.0%
Usd Price Per Share8.60-8.60-10.54-13.64-11.95-
Price to Earnings Ratio-27.67--27.67--39.23-72.07-3.80-
Price-to-Total Gains Ratio785.88-785.88--266.97--291.28--138.32-
Price to Book Ratio1.65-1.65-1.99-2.53-2.06-
Price-to-Total Gains Ratio785.88-785.88--266.97--291.28--138.32-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.63
Number of shares131
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.090.08
Usd Book Value Change Per Share-0.080.00
Usd Total Gains Per Share0.010.09
Gains per Quarter (131 shares)1.4311.16
Gains per Year (131 shares)5.7344.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
145-40-443235
291-79286480
3136-11981295125
4181-159141717170
5227-198202149215
6272-2382625711260
7318-2773230013305
8363-3173834314350
9408-3574438616395
10454-3965042818440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%5.05.00.050.0%5.05.00.050.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%6.04.00.060.0%6.04.00.060.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%7.03.00.070.0%

Fundamentals of Yuyu

About Yuyu Pharma Inc

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.

Fundamental data was last updated by Penke on 2024-04-14 14:46:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Yuyu Pharma Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Yuyu earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Yuyu to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -5.2% means that ₩-0.05 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Yuyu Pharma Inc:

  • The MRQ is -5.2%. The company is making a loss. -1
  • The TTM is -5.2%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-5.2%TTM-5.2%0.0%
TTM-5.2%YOY-4.3%-0.9%
TTM-5.2%5Y-1.0%-4.2%
5Y-1.0%10Y0.3%-1.3%
1.1.2. Return on Assets

Shows how efficient Yuyu is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Yuyu to the Drug Manufacturers - Specialty & Generic industry mean.
  • -3.6% Return on Assets means that Yuyu generated ₩-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Yuyu Pharma Inc:

  • The MRQ is -3.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM-3.6%0.0%
TTM-3.6%YOY-3.1%-0.6%
TTM-3.6%5Y-0.7%-2.9%
5Y-0.7%10Y0.1%-0.8%
1.1.3. Return on Equity

Shows how efficient Yuyu is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Yuyu to the Drug Manufacturers - Specialty & Generic industry mean.
  • -6.4% Return on Equity means Yuyu generated ₩-0.06 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Yuyu Pharma Inc:

  • The MRQ is -6.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.4%TTM-6.4%0.0%
TTM-6.4%YOY-5.1%-1.3%
TTM-6.4%5Y-1.4%-5.0%
5Y-1.4%10Y0.0%-1.4%

1.2. Operating Efficiency of Yuyu Pharma Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Yuyu is operating .

  • Measures how much profit Yuyu makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Yuyu to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Yuyu Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.4%+0.4%
TTM-5Y3.2%-3.2%
5Y3.2%10Y4.7%-1.5%
1.2.2. Operating Ratio

Measures how efficient Yuyu is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.64 means that the operating costs are ₩1.64 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Yuyu Pharma Inc:

  • The MRQ is 1.641. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.641. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.641TTM1.6410.000
TTM1.641YOY1.620+0.021
TTM1.6415Y1.546+0.095
5Y1.54610Y1.515+0.032

1.3. Liquidity of Yuyu Pharma Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Yuyu is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.03 means the company has ₩2.03 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Yuyu Pharma Inc:

  • The MRQ is 2.033. The company is able to pay all its short-term debts. +1
  • The TTM is 2.033. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.033TTM2.0330.000
TTM2.033YOY1.498+0.535
TTM2.0335Y2.372-0.339
5Y2.37210Y2.161+0.211
1.3.2. Quick Ratio

Measures if Yuyu is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Yuyu to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.45 means the company can pay off ₩0.45 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Yuyu Pharma Inc:

  • The MRQ is 0.451. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.451. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.451TTM0.4510.000
TTM0.451YOY0.415+0.036
TTM0.4515Y0.590-0.138
5Y0.59010Y0.713-0.124

1.4. Solvency of Yuyu Pharma Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Yuyu assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Yuyu to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.39 means that Yuyu assets are financed with 39.3% credit (debt) and the remaining percentage (100% - 39.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Yuyu Pharma Inc:

  • The MRQ is 0.393. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.393. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.393TTM0.3930.000
TTM0.393YOY0.368+0.025
TTM0.3935Y0.336+0.057
5Y0.33610Y0.324+0.012
1.4.2. Debt to Equity Ratio

Measures if Yuyu is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Yuyu to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 69.4% means that company has ₩0.69 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Yuyu Pharma Inc:

  • The MRQ is 0.694. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.694. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.694TTM0.6940.000
TTM0.694YOY0.615+0.079
TTM0.6945Y0.538+0.156
5Y0.53810Y0.501+0.037

2. Market Valuation of Yuyu Pharma Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Yuyu generates.

  • Above 15 is considered overpriced but always compare Yuyu to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -27.67 means the investor is paying ₩-27.67 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Yuyu Pharma Inc:

  • The EOD is -24.564. Based on the earnings, the company is expensive. -2
  • The MRQ is -27.674. Based on the earnings, the company is expensive. -2
  • The TTM is -27.674. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-24.564MRQ-27.674+3.110
MRQ-27.674TTM-27.6740.000
TTM-27.674YOY-39.231+11.558
TTM-27.6745Y72.071-99.744
5Y72.07110Y3.803+68.267
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Yuyu Pharma Inc:

  • The EOD is -37.647. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -42.414. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -42.414. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-37.647MRQ-42.414+4.766
MRQ-42.414TTM-42.4140.000
TTM-42.414YOY-20.860-21.553
TTM-42.4145Y-35.318-7.096
5Y-35.31810Y-25.340-9.977
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Yuyu is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.65 means the investor is paying ₩1.65 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Yuyu Pharma Inc:

  • The EOD is 1.466. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.651. Based on the equity, the company is underpriced. +1
  • The TTM is 1.651. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.466MRQ1.651-0.186
MRQ1.651TTM1.6510.000
TTM1.651YOY1.995-0.343
TTM1.6515Y2.532-0.881
5Y2.53210Y2.059+0.474
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Yuyu Pharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---108.070-108.0700%-180.755+67%4.920-2296%743.732-115%
Book Value Per Share--7437.3167437.3160%7545.387-1%7651.081-3%9080.690-18%
Current Ratio--2.0332.0330%1.498+36%2.372-14%2.161-6%
Debt To Asset Ratio--0.3930.3930%0.368+7%0.336+17%0.324+21%
Debt To Equity Ratio--0.6940.6940%0.615+13%0.538+29%0.501+38%
Dividend Per Share--123.696123.6960%124.381-1%116.777+6%141.487-13%
Eps---443.740-443.7400%-383.622-14%-106.606-76%-6.366-99%
Free Cash Flow Per Share---289.529-289.5290%-721.471+149%-380.810+32%-341.880+18%
Free Cash Flow To Equity Per Share---289.529-289.5290%-1276.986+341%-138.521-52%79.593-464%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--9415.327--------
Intrinsic Value_10Y_min---2453.244--------
Intrinsic Value_1Y_max---95.518--------
Intrinsic Value_1Y_min---351.137--------
Intrinsic Value_3Y_max--504.845--------
Intrinsic Value_3Y_min---970.068--------
Intrinsic Value_5Y_max--2059.856--------
Intrinsic Value_5Y_min---1491.147--------
Market Cap63870512000.000-211%198723224440.000198723224440.0000%246081406200.000-19%292480382048.000-32%210456445194.000-6%
Net Profit Margin---0.052-0.0520%-0.043-18%-0.010-81%0.003-1798%
Operating Margin----0%-0.0040%0.032-100%0.047-100%
Operating Ratio--1.6411.6410%1.620+1%1.546+6%1.515+8%
Pb Ratio1.466-13%1.6511.6510%1.995-17%2.532-35%2.059-20%
Pe Ratio-24.564+11%-27.674-27.6740%-39.231+42%72.071-138%3.803-828%
Price Per Share10900.000-13%12280.00012280.0000%15050.000-18%19486.000-37%17073.000-28%
Price To Free Cash Flow Ratio-37.647+11%-42.414-42.4140%-20.860-51%-35.318-17%-25.340-40%
Price To Total Gains Ratio697.564-13%785.880785.8800%-266.969+134%-291.285+137%-138.323+118%
Quick Ratio--0.4510.4510%0.415+9%0.590-23%0.713-37%
Return On Assets---0.036-0.0360%-0.031-15%-0.007-80%0.001-4556%
Return On Equity---0.064-0.0640%-0.051-20%-0.014-79%0.000-100%
Total Gains Per Share--15.62615.6260%-56.374+461%121.697-87%885.219-98%
Usd Book Value--84248958.41684248958.4160%86361828.987-2%81199423.550+4%68124870.795+24%
Usd Book Value Change Per Share---0.076-0.0760%-0.127+67%0.003-2296%0.521-115%
Usd Book Value Per Share--5.2065.2060%5.282-1%5.356-3%6.356-18%
Usd Dividend Per Share--0.0870.0870%0.087-1%0.082+6%0.099-13%
Usd Eps---0.311-0.3110%-0.269-14%-0.075-76%-0.004-99%
Usd Free Cash Flow---3279751.993-3279751.9930%-8257705.295+152%-4372715.770+33%-3059370.045-7%
Usd Free Cash Flow Per Share---0.203-0.2030%-0.505+149%-0.267+32%-0.239+18%
Usd Free Cash Flow To Equity Per Share---0.203-0.2030%-0.894+341%-0.097-52%0.056-464%
Usd Market Cap44709358.400-211%139106257.108139106257.1080%172256984.340-19%204736267.434-32%147319511.636-6%
Usd Price Per Share7.630-13%8.5968.5960%10.535-18%13.640-37%11.951-28%
Usd Profit---5026629.762-5026629.7620%-4191376.637-17%-1312718.735-74%-185444.095-96%
Usd Revenue--96046712.06996046712.0690%97216739.438-1%81304106.878+18%65158146.862+47%
Usd Total Gains Per Share--0.0110.0110%-0.039+461%0.085-87%0.620-98%
 EOD+2 -6MRQTTM+0 -0YOY+15 -195Y+12 -2310Y+9 -26

3.2. Fundamental Score

Let's check the fundamental score of Yuyu Pharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-24.564
Price to Book Ratio (EOD)Between0-11.466
Net Profit Margin (MRQ)Greater than0-0.052
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.451
Current Ratio (MRQ)Greater than12.033
Debt to Asset Ratio (MRQ)Less than10.393
Debt to Equity Ratio (MRQ)Less than10.694
Return on Equity (MRQ)Greater than0.15-0.064
Return on Assets (MRQ)Greater than0.05-0.036
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Yuyu Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.529
Ma 20Greater thanMa 5011,010.500
Ma 50Greater thanMa 10011,790.400
Ma 100Greater thanMa 20012,626.700
OpenGreater thanClose10,910.000
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets198,213,527
Total Liabilities77,857,872
Total Stockholder Equity112,187,629
 As reported
Total Liabilities 77,857,872
Total Stockholder Equity+ 112,187,629
Total Assets = 198,213,527

Assets

Total Assets198,213,527
Total Current Assets101,596,546
Long-term Assets96,616,981
Total Current Assets
Cash And Cash Equivalents 30,604,882
Short-term Investments 1,749,300
Net Receivables 20,801,220
Inventory 44,152,171
Other Current Assets 248,803
Total Current Assets  (as reported)101,596,546
Total Current Assets  (calculated)97,556,377
+/- 4,040,169
Long-term Assets
Property Plant Equipment 81,402,715
Goodwill 503,224
Intangible Assets 3,764,472
Long-term Assets Other 262,299
Long-term Assets  (as reported)96,616,981
Long-term Assets  (calculated)85,932,710
+/- 10,684,271

Liabilities & Shareholders' Equity

Total Current Liabilities49,975,203
Long-term Liabilities27,882,669
Total Stockholder Equity112,187,629
Total Current Liabilities
Short Long Term Debt 24,930,641
Accounts payable 10,951,761
Other Current Liabilities 2
Total Current Liabilities  (as reported)49,975,203
Total Current Liabilities  (calculated)35,882,404
+/- 14,092,799
Long-term Liabilities
Long term Debt 13,640,045
Capital Lease Obligations Min Short Term Debt836,466
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)27,882,669
Long-term Liabilities  (calculated)14,476,512
+/- 13,406,157
Total Stockholder Equity
Retained Earnings 20,170,851
Total Stockholder Equity (as reported)112,187,629
Total Stockholder Equity (calculated)20,170,851
+/- 92,016,779
Other
Capital Stock20,201,681
Common Stock Shares Outstanding 16,183
Net Debt 7,965,804
Net Invested Capital 148,165,825
Net Working Capital 51,621,343
Property Plant and Equipment Gross 124,711,146



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
101,400,550
104,327,188
111,299,322
121,491,153
135,226,315
137,718,627
154,901,007
192,985,288
195,205,073
198,213,527
198,213,527195,205,073192,985,288154,901,007137,718,627135,226,315121,491,153111,299,322104,327,188101,400,550
   > Total Current Assets 
45,573,668
49,015,687
56,641,299
63,470,374
68,869,662
65,053,890
64,466,555
98,887,922
96,357,746
101,596,546
101,596,54696,357,74698,887,92264,466,55565,053,89068,869,66263,470,37456,641,29949,015,68745,573,668
       Cash And Cash Equivalents 
11,118,641
9,833,291
18,905,063
19,812,435
26,966,546
26,846,233
20,322,824
50,263,468
25,838,582
30,604,882
30,604,88225,838,58250,263,46820,322,82426,846,23326,966,54619,812,43518,905,0639,833,29111,118,641
       Short-term Investments 
550,000
500,000
509,587
500,000
545,950
0
180,000
0
4,939,055
1,749,300
1,749,3004,939,0550180,0000545,950500,000509,587500,000550,000
       Net Receivables 
25,351,819
25,183,030
22,116,477
21,597,273
22,431,352
20,500,098
17,461,736
19,239,859
21,744,853
20,801,220
20,801,22021,744,85319,239,85917,461,73620,500,09822,431,35221,597,27322,116,47725,183,03025,351,819
       Inventory 
8,223,956
12,789,107
14,033,761
19,593,377
15,615,956
17,015,981
23,688,893
25,225,284
39,832,040
44,152,171
44,152,17139,832,04025,225,28423,688,89317,015,98115,615,95619,593,37714,033,76112,789,1078,223,956
       Other Current Assets 
257,536
663,319
937,568
1,768,941
2,856,131
541,765
269,599
491,056
692,939
248,803
248,803692,939491,056269,599541,7652,856,1311,768,941937,568663,319257,536
   > Long-term Assets 
0
0
54,658,023
58,020,778
66,356,653
72,664,736
90,434,452
94,097,366
98,847,326
96,616,981
96,616,98198,847,32694,097,36690,434,45272,664,73666,356,65358,020,77854,658,02300
       Property Plant Equipment 
46,518,809
47,225,560
47,601,435
49,722,036
57,811,651
63,262,522
78,073,296
80,341,360
81,371,282
81,402,715
81,402,71581,371,28280,341,36078,073,29663,262,52257,811,65149,722,03647,601,43547,225,56046,518,809
       Goodwill 
50,829
50,829
50,829
50,829
50,829
50,829
50,829
50,829
50,829
503,224
503,22450,82950,82950,82950,82950,82950,82950,82950,82950,829
       Long Term Investments 
4,637,013
3,652,510
2,722,135
3,701,904
3,927,007
4,025,899
0
0
0
0
00004,025,8993,927,0073,701,9042,722,1353,652,5104,637,013
       Intangible Assets 
2,085,666
2,172,442
1,940,474
1,822,048
1,651,933
1,924,693
3,785,501
4,087,102
3,666,483
3,764,472
3,764,4723,666,4834,087,1023,785,5011,924,6931,651,9331,822,0481,940,4742,172,4422,085,666
       Long-term Assets Other 
0
0
499,957
498,676
498,677
498,676
498,677
498,677
262,299
262,299
262,299262,299498,677498,677498,676498,677498,676499,95700
> Total Liabilities 
29,911,537
30,596,556
33,008,376
38,657,441
48,354,059
47,173,960
37,864,566
64,300,209
71,831,031
77,857,872
77,857,87271,831,03164,300,20937,864,56647,173,96048,354,05938,657,44133,008,37630,596,55629,911,537
   > Total Current Liabilities 
22,900,739
29,206,789
31,187,838
35,483,638
27,787,568
42,495,630
18,398,703
30,014,749
64,315,528
49,975,203
49,975,20364,315,52830,014,74918,398,70342,495,63027,787,56835,483,63831,187,83829,206,78922,900,739
       Short-term Debt 
840,524
17,444,000
16,900,000
18,070,000
12,366,197
23,437,558
0
0
0
0
000023,437,55812,366,19718,070,00016,900,00017,444,000840,524
       Short Long Term Debt 
840,524
17,444,000
16,900,000
18,070,000
12,366,197
23,437,558
4,388,496
10,012,370
36,882,096
24,930,641
24,930,64136,882,09610,012,3704,388,49623,437,55812,366,19718,070,00016,900,00017,444,000840,524
       Accounts payable 
3,224,371
4,879,900
4,646,888
8,453,250
5,056,812
6,385,086
5,286,763
8,982,265
15,840,532
10,951,761
10,951,76115,840,5328,982,2655,286,7636,385,0865,056,8128,453,2504,646,8884,879,9003,224,371
       Other Current Liabilities 
14,183,970
6,456,147
9,151,331
8,291,575
9,508,259
11,240,200
6,821,285
9,051,746
9,437,099
2
29,437,0999,051,7466,821,28511,240,2009,508,2598,291,5759,151,3316,456,14714,183,970
   > Long-term Liabilities 
0
0
1,820,538
3,173,803
20,566,490
4,678,330
19,465,862
34,285,461
7,515,503
27,882,669
27,882,6697,515,50334,285,46119,465,8624,678,33020,566,4903,173,8031,820,53800
       Capital Lease Obligations 
0
0
0
0
0
822,480
969,614
697,754
793,825
836,466
836,466793,825697,754969,614822,48000000
       Long-term Liabilities Other 
0
0
0
0
1
0
0
0
0
1
1000010000
> Total Stockholder Equity
69,121,785
71,561,261
77,161,710
81,963,193
85,792,395
88,694,578
114,359,483
124,281,212
116,816,212
112,187,629
112,187,629116,816,212124,281,212114,359,48388,694,57885,792,39581,963,19377,161,71071,561,26169,121,785
   Common Stock
6,361,758
6,538,246
6,538,246
6,745,427
6,745,427
6,745,427
8,412,087
17,609,191
17,609,191
0
017,609,19117,609,1918,412,0876,745,4276,745,4276,745,4276,538,2466,538,2466,361,758
   Retained Earnings 
29,110,058
27,520,344
31,851,944
34,766,215
39,690,638
42,716,573
41,914,283
36,540,363
31,395,871
20,170,851
20,170,85131,395,87136,540,36341,914,28342,716,57339,690,63834,766,21531,851,94427,520,34429,110,058
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
8,606,222
8,905,472
8,876,777
9,384,616
6,624,950
6,302,236
13,639,237
13,107,048
12,571,776
0
012,571,77613,107,04813,639,2376,302,2366,624,9509,384,6168,876,7778,905,4728,606,222



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue137,209,589
Cost of Revenue-88,312,980
Gross Profit48,896,60848,896,608
 
Operating Income (+$)
Gross Profit48,896,608
Operating Expense-136,845,051
Operating Income364,537-87,948,443
 
Operating Expense (+$)
Research Development7,187,636
Selling General Administrative15,898,981
Selling And Marketing Expenses0
Operating Expense136,845,05123,086,617
 
Net Interest Income (+$)
Interest Income896,735
Interest Expense-2,553,778
Other Finance Cost-1
Net Interest Income-1,657,042
 
Pretax Income (+$)
Operating Income364,537
Net Interest Income-1,657,042
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,442,145364,537
EBIT - interestExpense = -2,553,778
-7,180,900
-4,627,122
Interest Expense2,553,778
Earnings Before Interest and Taxes (EBIT)0-2,888,367
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-5,442,145
Tax Provision-98,436
Net Income From Continuing Ops-5,540,582-5,540,582
Net Income-7,180,900
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,657,042
 

Technical Analysis of Yuyu
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Yuyu. The general trend of Yuyu is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Yuyu's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Yuyu Pharma Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 11,100 < 11,390 < 11,820.

The bearish price targets are: 10,530 > 9,920 > 9,850.

Tweet this
Yuyu Pharma Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Yuyu Pharma Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Yuyu Pharma Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Yuyu Pharma Inc. The current macd is -254.34809794.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Yuyu price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Yuyu. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Yuyu price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Yuyu Pharma Inc Daily Moving Average Convergence/Divergence (MACD) ChartYuyu Pharma Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Yuyu Pharma Inc. The current adx is 23.11.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Yuyu shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Yuyu Pharma Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Yuyu Pharma Inc. The current sar is 10,654.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Yuyu Pharma Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Yuyu Pharma Inc. The current rsi is 41.53. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Yuyu Pharma Inc Daily Relative Strength Index (RSI) ChartYuyu Pharma Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Yuyu Pharma Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Yuyu price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Yuyu Pharma Inc Daily Stochastic Oscillator ChartYuyu Pharma Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Yuyu Pharma Inc. The current cci is -48.69857263.

Yuyu Pharma Inc Daily Commodity Channel Index (CCI) ChartYuyu Pharma Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Yuyu Pharma Inc. The current cmo is -12.49821602.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Yuyu Pharma Inc Daily Chande Momentum Oscillator (CMO) ChartYuyu Pharma Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Yuyu Pharma Inc. The current willr is -51.94805195.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Yuyu is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Yuyu Pharma Inc Daily Williams %R ChartYuyu Pharma Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Yuyu Pharma Inc.

Yuyu Pharma Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Yuyu Pharma Inc. The current atr is 282.56.

Yuyu Pharma Inc Daily Average True Range (ATR) ChartYuyu Pharma Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Yuyu Pharma Inc. The current obv is 44,029.

Yuyu Pharma Inc Daily On-Balance Volume (OBV) ChartYuyu Pharma Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Yuyu Pharma Inc. The current mfi is 48.76.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Yuyu Pharma Inc Daily Money Flow Index (MFI) ChartYuyu Pharma Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Yuyu Pharma Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Yuyu Pharma Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Yuyu Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.529
Ma 20Greater thanMa 5011,010.500
Ma 50Greater thanMa 10011,790.400
Ma 100Greater thanMa 20012,626.700
OpenGreater thanClose10,910.000
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Yuyu with someone you think should read this too:
  • Are you bullish or bearish on Yuyu? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Yuyu? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Yuyu Pharma Inc

I send you an email if I find something interesting about Yuyu Pharma Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Yuyu Pharma Inc.

Receive notifications about Yuyu Pharma Inc in your mailbox!